These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7769100)

  • 1. Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice.
    Janes CH; Dickson ER; Okazaki R; Bonde S; McDonagh AF; Riggs BL
    J Clin Invest; 1995 Jun; 95(6):2581-6. PubMed ID: 7769100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bilirubin and sera from jaundiced patients on osteoblasts: contribution to the development of osteoporosis in liver diseases.
    Ruiz-Gaspà S; Martinez-Ferrer A; Guañabens N; Dubreuil M; Peris P; Enjuanes A; Martinez de Osaba MJ; Alvarez L; Monegal A; Combalia A; Parés A
    Hepatology; 2011 Dec; 54(6):2104-13. PubMed ID: 21837749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells.
    Dubreuil M; Ruiz-Gaspà S; Guañabens N; Peris P; Alvarez L; Monegal A; Combalia A; Parés A
    Liver Int; 2013 Aug; 33(7):1029-38. PubMed ID: 23560764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Care of the cholestatic patient.
    Gossard AA
    Clin Liver Dis; 2013 May; 17(2):331-44. PubMed ID: 23540506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic cholestatic liver diseases: clues from histopathology for pathogenesis.
    Pollheimer MJ; Fickert P; Stieger B
    Mol Aspects Med; 2014 Jun; 37():35-56. PubMed ID: 24141039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic analysis of cholestatic liver damage in mice.
    Yang R; Zhao Q; Hu DD; Xiao XR; Huang JF; Li F
    Food Chem Toxicol; 2018 Oct; 120():253-260. PubMed ID: 30009888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.
    Trottier J; Białek A; Caron P; Straka RJ; Heathcote J; Milkiewicz P; Barbier O
    Dig Liver Dis; 2012 Apr; 44(4):303-10. PubMed ID: 22169272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
    Nakanishi Y; Saxena R
    Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis.
    Ruiz-Gaspà S; Dubreuil M; Guañabens N; Combalia A; Peris P; Monegal A; Parés A
    Eur J Clin Invest; 2014 Dec; 44(12):1206-14. PubMed ID: 25331234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholestatic liver diseases: new strategies for prevention and treatment of hepatobiliary and cholestatic diseases.
    van de Meeberg PC; Wolfhagen FH; van Erpecum KJ; van Berge Henegouwen GP
    Neth J Med; 1995 Jul; 47(1):30-5. PubMed ID: 7651564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of 7alpha-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans.
    Sauter G; Berr F; Beuers U; Fischer S; Paumgartner G
    Hepatology; 1996 Jul; 24(1):123-6. PubMed ID: 8707250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe jaundice in malignant lymphoma. Report of two autopsy cases.
    Sugimoto M; Mizukami H; Mao K; Aikawa K; Sadamoto T; Abei T
    Jpn J Med; 1986 Feb; 25(1):69-72. PubMed ID: 3712864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of cholestatic liver disease].
    Pleşa A
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):733-6. PubMed ID: 14756010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pruritus -- fatigue -- icterus. Bile obstruction has many faces].
    Stiefelhagen P
    MMW Fortschr Med; 2003 Dec; 145(49):4-8. PubMed ID: 14963983
    [No Abstract]   [Full Text] [Related]  

  • 15. [Predictive value of umbilical cord blood bilirubin level for subsequent neonatal jaundice].
    Sun G; Wang YL; Liang JF; Du LZ
    Zhonghua Er Ke Za Zhi; 2007 Nov; 45(11):848-52. PubMed ID: 18282419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilirubin and bile acids in osteocytes and bone tissue. Potential role in the cholestatic-induced osteoporosis.
    Ruiz-Gaspà S; Guañabens N; Jurado S; Combalia A; Peris P; Monegal A; Parés A
    Liver Int; 2020 Nov; 40(11):2767-2775. PubMed ID: 32749754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [THE EFFECT OF TOTAL BILE DUCT OBSTRUCTION ON THE LIVER AND BILIRUBIN CONTENT OF THE SERUM UNDER THE INFLUENCE OF SOLU-DECORTIN].
    NASSR-ESFAHANI H; EGER W
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1964 Mar; 305():358-70. PubMed ID: 14189972
    [No Abstract]   [Full Text] [Related]  

  • 18. Neonatal cholestasis: a red alert for the jaundiced newborn.
    Pashankar D; Schreiber RA
    Can J Gastroenterol; 2000 Nov; 14 Suppl D():67D-72D. PubMed ID: 11110615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis and Management of Pruritus in PBC and PSC.
    Kremer AE; Namer B; Bolier R; Fischer MJ; Oude Elferink RP; Beuers U
    Dig Dis; 2015; 33 Suppl 2():164-75. PubMed ID: 26641452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathology of cholestasis.
    Li MK; Crawford JM
    Semin Liver Dis; 2004 Feb; 24(1):21-42. PubMed ID: 15085484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.